Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Jul;9(4):290-9.
doi: 10.1007/s11912-007-0036-x.

Chemotherapy-induced neuropathy

Affiliations
Review

Chemotherapy-induced neuropathy

Anjali Bhagra et al. Curr Oncol Rep. 2007 Jul.

Abstract

Peripheral neuropathy is a common dose-limiting toxicity of chemotherapy. Chemotherapy-induced peripheral neuropathy (CIPN) causes numerous debilitating symptoms, impairs functional capacity, and results in dose reductions or possible cessation of chemotherapy. Analgesic or neurotropic agents are only modestly effective in treating neuropathic symptoms. Animal and human studies into the pathogenesis of CIPN have demonstrated heterogeneity in the mechanism(s) of nerve injury caused by individual agents, which may partly explain the wide variation in the resultant symptoms. Development of optimal therapeutic measures to treat CIPN requires continued research into the pathophysiologic basis of nerve injury, identification of risk factors for individual patients, development of reproducible and easy-to-use measurement scales, and finally, the performance of appropriately designed clinical trials to evaluate potentially promising agents.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Brain. 2004 Apr;127(Pt 4):929-39 - PubMed
    1. N Engl J Med. 1992 May 7;326(19):1250-6 - PubMed
    1. J Clin Oncol. 1999 Aug;17(8):2341-54 - PubMed
    1. Anticancer Drugs. 2003 Nov;14(10):785-92 - PubMed
    1. Eur J Cancer. 1997 Aug;33(9):1393-9 - PubMed

MeSH terms

LinkOut - more resources